WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 18.08.2018 at 9:00 AM CEST
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018103884) USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THE THERAPEUTIC POTENTIAL OF DRUGS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/103884 International Application No.: PCT/EP2017/001406
Publication Date: 14.06.2018 International Filing Date: 05.12.2017
IPC:
A61K 39/395 (2006.01) ,C07K 16/30 (2006.01) ,A61K 39/00 (2006.01)
Applicants: OGD2 PHARMA[FR/FR]; 3 Chemin du pressoir chenaie 44100 Nantes, FR
UNIVERSITE DE NANTES[FR/FR]; 1 Quai de Tourville 44000 NANTES, FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)[FR/FR]; 3, rue Michel Ange 75794 Paris Cedex 16, FR
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)[FR/FR]; 101 rue de Tolbiac 75013 Paris, FR
INSTITUT DE CANCEROLOGIE DE L'OUEST[FR/FR]; 15 rue André Boquel 49055 Angers Cedex 02, FR
Inventors: BIRKLE, Stéphane; FR
FLEURENCE, Julien; FR
FARAJ, Sébastien; FR
LE DOUSSAL, Jean-Marc; CH
COCHONNEAU, Denis; FR
TERME, Mickaël; FR
ASSOULINE, Brigitte; FR
Agent: BARDOT, Willy; SIMODORO 1 Place des prêcheurs 13100 Aix-en-Provence, CH
Priority Data:
16002576.305.12.2016EP
Title (EN) USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THE THERAPEUTIC POTENTIAL OF DRUGS
(FR) UTILISATION D'UN ANTICORPS CONTRE LE GANGLIOSIDE GD2 O-ACÉTYLÉ DANS LE BUT D'AMÉLIORER LE POTENTIEL THÉRAPEUTIQUE DE MÉDICAMENTS
Abstract:
(EN) The present invention relates to a method for delivery of an anti-cancer agent into a cell expressing the OAcGD2 ganglioside by using an antibody recognizing the OAcGD2 ganglioside.
(FR) La présente invention concerne une méthode destinée à administrer un agent anticancéreux à une cellule exprimant le gangliosde OAcGD2 par le biais d'un anticorps reconnaissant le ganglioside OAcGD2.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)